About Us
Pimbio B.V. is a privately held Design and Prototyping Studio founded in 2014 to develop new and promising microfluidic devices for bioengineering physiologically relevant living tissue for different applications. PimCell® is the commercial brand of Pimbio, specializing in the sales of our advanced microfluidic technologies.
Our Market
Pimbio supports scientists interested in animal free research by providing our patented organ-on-a-chip technology to emulate human 3D anatomy and physiology in vitro.
Current issues
Existing barrier free microfluidic devices are not adapted for culturing and vascularization of relative large 3D tissue like cerebral brain organoids. This is because of very small volumes of cell culture chambers. These products also have relative large space inside microfluidic system without sufficient perfusion. That creates large dead volume inside in vitro models and limits throughput.
Our proposition
Pimbio offers its patented advanced microfluidic PimCell® platform and customized variants for integration with validated cellular in vitro models. We seek strategic partnerships to develop innovative, ready-to-use organ-on-a-chip in vitro models that enable researchers to conduct experiments immediately without additional setup or optimization.
Your advantage
Your direct advantage is an opportunity to create or to upgrade your existing in vitro model for producing more valuable and reliable data.
Value
This will boost your research and faster development of new drugs and other products.
Vision
Our vision is to operate as a market leader in development and commercialization of microfluidic devices for 3D in vitro bioengineering.
Mission
Our mission is to provide our 3Rs and user friendly technology to the research- and industrial community, improving people's lives.
